+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment



Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment



Human Brain Mapping 37(3): 968-977



Mild cognitive impairment (MCI) and visual hallucinations (VH) are common co-morbidities and risk factors for dementia in Parkinson's disease (PD). The relative value of each of them in the progression to dementia is unknown. We investigated cognitive impairment and cerebral hypometabolism in PD-MCI patients with VH (VH-positive) and without (VH-negative). Twenty-one PD-MCI patients (12 VH-negative, nine VH-positive) and 19 controls were studied using a comprehensive neuropsychological battery and [18F]-Fluorodeoxyglucose positron emission tomography (FDG-PET). The neuropsychological assessment was repeated after 30 months. Regional FDG uptake was analyzed using statistical parametric mapping. VH-positive patients had lower FDG uptake bilaterally in the occipital, and parietal cortex, right temporal lobe and in the left cingulum compared with VH-negative patients. The two groups showed no significant differences in clinical characteristics and cognitive status at baseline. After 30 months of follow-up, three (25%) and four (50%) of the VH-negative and VH-positive patients, respectively, had progressed to dementia. Even in the absence of significant cognitive differences, PD-MCI patients with VH exhibit more severe cerebral hypometabolism and had a higher rate of progression to dementia than VH-negative patients, supporting the importance of VH and cerebral hypometabolism in establishing the risk of dementia in PD-MCI.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058851261

Download citation: RISBibTeXText

PMID: 26663702

DOI: 10.1002/hbm.23080


Related references

Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease. European Journal of Nuclear Medicine and Molecular Imaging 39(11): 1767-1777, 2013

Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease. Dementia and Geriatric Cognitive Disorders 44(1-2): 12-24, 2017

Mild cognitive impairment as a risk factor for Parkinson's disease dementia. Movement Disorders 32(7): 1056-1065, 2017

Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia. Parkinsonism and Related Disorders 20(4): 394-399, 2014

Cognitive profiles of patients with mild cognitive impairment or dementia in Alzheimer's or Parkinson's disease. Dementia and Geriatric Cognitive Disorders Extra 3(1): 102-112, 2013

Dementia and mild cognitive impairment in patients with Parkinson's disease. Arquivos de Neuro-Psiquiatria 67(2b): 423-427, 2010

Dementia and mild cognitive impairment in patients with Parkinson's disease. Arquivos de Neuro-Psiquiatria 67(2b): 423-427, 2009

The difference of mild cognitive impairment in Parkinson's disease from amnestic mild cognitive impairment: Deeper power decrement and no phase-locking in visual event-related responses. International Journal of Psychophysiology 2019, 2019

Dementia, mild cognitive impairment and quantitative EEG in patients with Parkinson's disease. Clinical Eeg and Neuroscience 40(3): 168-172, 2009

Cognitive dysfunction in patients with very mild Alzheimer's disease and amnestic mild cognitive impairment showing hemispheric asymmetries of hypometabolism on ¹⁸F-FDG PET. International Journal of Geriatric Psychiatry 31(1): 41-48, 2016

Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism. Neurology 77(14): 1357-1362, 2011

Impaired financial abilities in Parkinson's disease patients with mild cognitive impairment and dementia. Parkinsonism and Related Disorders 19(11): 986-990, 2014

Exploring the Phenotype in Mild Cognitive Impairment to Aid the Prediction of Those at Risk of Transitioning to Parkinson Disease and Dementia With Lewy Bodies. Journal of Geriatric Psychiatry and Neurology 30(4): 196-205, 2018

Anosognosia for cognitive and behavioral symptoms in Parkinson's disease with mild dementia and mild cognitive impairment: Frequency and neuropsychological/neuropsychiatric correlates. Parkinsonism and Related Disorders 54: 62-67, 2018

Incidence of Mild Cognitive Impairment and Dementia in Parkinson's Disease: The Parkinson's Disease Cognitive Impairment Study. Frontiers in Aging Neuroscience 11: 21, 2019